4/A

PRIMARY DOCUMENT

Company: IONIS PHARMACEUTICALS INC
Filed: March 27, 2020
Period of Report: March 17, 2020
Accession Number: 0000874015-20-000064

View Document ↗ View on SEC.gov ↗